Literature DB >> 17586193

Headache in children with sickle cell disease: prevalence and associated factors.

Alison E Niebanck1, Avrum N Pollock, Kim Smith-Whitley, Leslie J Raffini, Robert A Zimmerman, Kwaku Ohene-Frempong, Janet L Kwiatkowski.   

Abstract

OBJECTIVE: To compare the prevalence of frequent headache in children with sickle cell disease (SCD) to that of black control subjects and to assess factors associated with headache in SCD. STUDY
DESIGN: In this cross-sectional study, a headache questionnaire was administered to subjects with SCD and black control subjects. Subjects answered supplementary questions about SCD complications. Clinical and radiographic information were abstracted from medical charts for subjects with SCD.
RESULTS: Children (n = 241) with SCD and 141 control subjects were studied; 32.4% (95% CI 26.5%-38.7%) of subjects with SCD reported having headaches at least weekly, similar to control subjects at 27% (95% CI 19.8%-35.1%, P = NS); however, in children <13 years, headache was more common in subjects with SCD than in control subjects (24% vs 9.7%, P = .013). The prevalence of headache was similar among the different SCD genotypes. Factors associated with frequent headaches in subjects with SCD included older age, frequent vaso-occlusive pain episodes, symptoms of obstructive sleep apnea, and cerebral vessel stenosis detected by magnetic resonance angiography.
CONCLUSION: The prevalence of headaches in children with SCD is similar to the general population; however, younger children with SCD report headaches more frequently than control subjects. The cause of headache is likely multifactorial, and SCD-specific factors may contribute.

Entities:  

Mesh:

Year:  2007        PMID: 17586193      PMCID: PMC2538680          DOI: 10.1016/j.jpeds.2007.02.015

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  22 in total

1.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

2.  MRI/MRA evaluation of sickle cell disease of the brain.

Authors:  Robert A Zimmerman
Journal:  Pediatr Radiol       Date:  2005-02-10

3.  PedMIDAS: development of a questionnaire to assess disability of migraines in children.

Authors:  A D Hershey; S W Powers; A L Vockell; S LeCates; M A Kabbouche; M K Maynard
Journal:  Neurology       Date:  2001-12-11       Impact factor: 9.910

4.  Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

Authors:  Charles H Pegelow; Eric A Macklin; Franklin G Moser; Winfred C Wang; Jacqueline A Bello; Scott T Miller; Elliott P Vichinsky; Michael R DeBaun; Ludovico Guarini; Robert A Zimmerman; Donald P Younkin; Dianne M Gallagher; Thomas R Kinney
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

5.  Migraine without aura and migrainous disorder in children; International Headache Society (IHS) and revised IHS criteria.

Authors:  A Cano; E Palomeras; S Alfonso; D Ortega; P Sanz; P Fossas
Journal:  Cephalalgia       Date:  2000-09       Impact factor: 6.292

6.  Self-reported headache frequency in Canadian adolescents: validation and follow-up.

Authors:  Joseph M Dooley; K E Gordon; E P Wood
Journal:  Headache       Date:  2005-02       Impact factor: 5.887

7.  Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study.

Authors:  Miguel R Abboud; Joel Cure; Suzanne Granger; Dianne Gallagher; Lewis Hsu; Winfred Wang; Gerald Woods; Brian Berman; Don Brambilla; Charles Pegelow; Jonathan Lewin; Robert A Zimmermann; Robert J Adams
Journal:  Blood       Date:  2003-12-18       Impact factor: 22.113

8.  Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography.

Authors:  Toshio Moritani; Yuji Numaguchi; Norma B Lemer; Martha K Rozans; Avin E Robinson; Akio Hiwatashi; Per-Lennart Westesson
Journal:  Clin Imaging       Date:  2004 May-Jun       Impact factor: 1.605

9.  Moyamoya disease presented with migrainelike headache in a 4-year-old girl.

Authors:  Kürşad Aydin; Cetin Okuyaz; Kivilcim Gücüyener; Ayşe Serdaroğlu; Sergin Akpek
Journal:  J Child Neurol       Date:  2003-05       Impact factor: 1.987

Review 10.  Primary headaches in children and adolescents.

Authors:  L Grazzi
Journal:  Neurol Sci       Date:  2004-10       Impact factor: 3.307

View more
  6 in total

Review 1.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

2.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 3.  Headache and Facial Pain in Sickle Cell Disease.

Authors:  Angeliki Vgontzas; Larry Charleston; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2016-03

Review 4.  Sickle Cell Disease and Stroke: Diagnosis and Management.

Authors:  Courtney Lawrence; Jennifer Webb
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

5.  Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Authors:  Michael M Dowling; Michael J Noetzel; Mark J Rodeghier; Charles T Quinn; Deborah G Hirtz; Rebecca N Ichord; Janet L Kwiatkowski; E Steven Roach; Fenella J Kirkham; James F Casella; Michael R DeBaun
Journal:  J Pediatr       Date:  2014-02-13       Impact factor: 4.406

Review 6.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.